Performance overview
Value at beginning of month: $148,917.34
Value at end of month: $152,872.55
Month over month change: +2.66%
Total IRR: 21.16%
Related indices, monthly change
NASDAQ: +1.76%
IVV (iShares Core S&P 500): +1.15%
IBB (iShares NASDAQ Biotechnology Index): -2.88%
MXI (iShares Global Materials): +1.33%
VEGI (iShares MSCI Global Agriculture Producers): -0.82%
ICLN (iShares Clean Energy): +1.03%
Individual performances
There were several companies that grew by double digit percentages this month, but the real surprising company was Amyris. Due to another disappointing year of earnings, investors may be getting suspicious that Amyris may ever be able to reach productivity. Their stock price fell over 50% after their earnings release, and now sits at its lowest price ever.
Changes made to index
Added Precision Biosciences after their IPO.
You can view the index here.
Allocation as of March 29, 2019
